The Claim
Bioinformatics analysis of gene expression in 278 kidney renal papillary cell carcinoma (KIRP) tumors identifies enrichment of biological pathways associated with extracellular matrix degradation, immune microenvironment regulation, and signaling pathways including PI3K-Akt, TNF, and IL-17.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Analysis of gene activity in 278 kidney cancer tumors shows increased activity in biological pathways involved in breaking down the extracellular matrix, regulating the immune environment around the tumor, and activating PI3K-Akt, TNF, and IL-17 signaling pathways.
See the scientific wording
Bioinformatics analysis of gene expression in 278 kidney renal papillary cell carcinoma (KIRP) tumors reveals enrichment of pathways related to extracellular matrix degradation, immune microenvironment regulation, and signaling pathways including PI3K-Akt, TNF, and IL-17, suggesting these biological processes may be involved in KIRP progression.
Cancer cells in the kidney break down surrounding tissue to spread, while immune cells in the area become confused and stop attacking the tumor. This allows the cancer to grow and survive, fueled by signals that tell cells to multiply and avoid death.
What the research says
1 studyThis study found that in kidney cancer tumors, certain biological processes like tissue breakdown and immune system activity are turned up—just like the claim said. Even though it looked at a chemical (aspartame) that might cause the cancer, the gene patterns it found match what the claim describes.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.